¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-17
±³À°ÀÏÀÚ : 2021-04-17
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í ±³¼ö ¹× °³¿øÀÇ: 20000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ: 10000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ09:00~09:20 What Is Clonal Hematopoiesis of Indeterminate Potential (CHIP)?  S. Jaiswal(Stanford Univ. USA) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ09:20~09:40 CHIP, A Common Risk Factor for Cardiology and Oncology  °í¿µÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ09:40~10:00 CHIP and Atherosclerotic Cardiovascular Disease  ÀÌÈñ¼±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ10:00~10:20 How Will We Use CHIP in Clinical Practice?  À̼±±â(ÇѸ²ÀÇ´ë) 
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀΠ10:20~10:30 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ04¿ù 17ÀÏ  10:30~10:40 Break  () 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ10:40~11:00 Role of Myocardial Viability Imaging in Post-STICH Era: Interventionist Perspectives  ¾ÈÁ¤¹Î(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ11:00~11:20 Viability Imaging: ECHO and Cardiologist Perspectives  Á¶Àͼº(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ11:20~11:40 Myocardial Viability: MRI  ¹Úöȯ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ11:40~12:00 Myocardial Viability: PET/SPECT  Á¶»ó°Ç(Àü³²ÀÇ´ë) 
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀΠ12:00~12:10 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ04¿ù 17ÀÏ  12:10~12:15 Break  () 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ12:15~12:35 Combination Therapy of Antihypertensive Drugs for Cardiovascular Protection  ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ12:35~12:55 Why Should We Consider Strongly Rosuvastatin Ezetimibe Combination Therapy?  ÇÑÁ¤±Ô(¼­¿ïÀÇ´ë) 
È޽Ġ04¿ù 17ÀÏ  12:55~13:10 Break  () 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ13:10~13:30 Diverse causes of pulmonary vein stenosis  ±èÁö³ª(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ13:30~13:50 Diagnosis and medical management of pulmonary vein stenosis  Á¤¼öÀÎ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ13:50~14:10 Transcatheter treatment of pulmonary vein stenosis  ±è±â¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ14:10~14:30 Best surgical strategy to prevent re-stenosis of pulmonary vein stenosis  ¹Úõ¼ö(¿ï»êÀÇ´ë) 
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀΠ14:30~14:40 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ04¿ù 17ÀÏ  14:40~14:50 Break  () 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ14:50~15:10 TAVR Valve Leaflet Thrombosis and a Role of CFD Analysis  ÀÌ°ü¿ë(°¡Å縮ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ15:10~15:30 Hemodynamic Characteristics Around a Vulnerable Stenosis  ÃÖ¿ì¶ô(POSTECH) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ15:30~15:50 Deep Learning Models for Predicting Lung Diseases Such as COPD and COVID-19  ÃÖ»óÇå(°æºÏ´ëÇб³) 
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀΠ15:50~16:10 Convolutional Neural Network Method for Classification of Heart Sounds  À¯µ¿Çö(POSTECH) 
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀΠ16:10~16:20 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021³â Çѱ¹È£½ºÇǽº¡¤¿ÏÈ­ÀÇ·áÇÐȸ Ãá°è¿¬¼ö°­Á : 2021-04-17
´ÙÀ½±Û ¼­¿ïƯº°½ÃÀÇ»çȸ (¿Â¶óÀÎ) 2021³â ¼ÛÆı¸ÀÇ»çȸ ¿Â¶óÀÎ ¿¬¼ö±³À°(4¿ù) : 2021-04-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 9 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 10 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 10 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 8 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 12 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 16 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 11 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 6 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 8 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 13 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 13 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 5 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 18 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 10 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 11 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷